Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
67 recruiting
Showing 1–20 of 134 trials
Recruiting
Phase 1Phase 2
A Phase I/II Study of WJB001 Combination Therapy on Safety and Efficacy for Advanced Solid Tumors
Advanced Solid Tumor
Wigen Biomedicine Technology (Shanghai) Co., Ltd.86 enrolled10 locationsNCT06953323
Recruiting
Phase 1
Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors
Advanced Solid Tumor
BeOne Medicines308 enrolled37 locationsNCT06233942
Recruiting
Phase 1Phase 2
Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
Advanced Solid TumorMalignant MesotheliomaMetastatic Malignant Solid Tumor
InSilico Medicine Hong Kong Limited160 enrolled10 locationsNCT06566079
Recruiting
Phase 2
A Study Comparing BL-M07D1 With DS-8201 in Patients With HR-Positive, HER2-Low Expressing Recurrent/Metastatic Breast Cancer
Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.120 enrolledNCT07678957
Recruiting
Not Applicable
Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H)
Rectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences1,384 enrolled8 locationsNCT06146946
Recruiting
Phase 1
Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors
Advanced Solid Tumor
BeOne Medicines153 enrolled26 locationsNCT06598800
Recruiting
Phase 1
A Study of BG-C477 in Participants With Advanced Solid Tumors
Advanced Solid Tumors
BeOne Medicines310 enrolled54 locationsNCT06596473
Recruiting
Phase 3
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
Small Cell Lung Cancer
Zai Lab (Shanghai) Co., Ltd.480 enrolled76 locationsNCT07218146
Recruiting
Phase 1Phase 2
Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer
Esophageal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.105 enrolled30 locationsNCT07367516
Recruiting
Phase 3
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Gastroesophageal Junction AdenocarcinomaMetastatic Gastric Adenocarcinoma
BeOne Medicines351 enrolled95 locationsNCT07043400
Recruiting
Phase 1
A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors
Advanced Solid TumorSolid Tumors
BeOne Medicines63 enrolled14 locationsNCT07181681
Recruiting
Phase 1
An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid Tumors
Advanced Solid Tumor
BeOne Medicines525 enrolled98 locationsNCT06589596
Recruiting
Phase 1
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
Advanced Solid Tumor
BeOne Medicines105 enrolled21 locationsNCT07226349
Recruiting
Phase 1
A Study of SI-B036 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors
Breast CancerSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd.39 enrolledNCT07753226
Recruiting
Phase 1Phase 2
A Clinical Trial on the Efficacy and Safety of TQB6411 for Injection
Advanced Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.465 enrolled38 locationsNCT07367529
Recruiting
Phase 3
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Extensive-stage Small-cell Lung Cancer
BioNTech SE621 enrolled221 locationsNCT06712355
Recruiting
Phase 1Phase 2
Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors
Locally Advanced/Metastatic Solid Tumors
InSilico Medicine Hong Kong Limited146 enrolled10 locationsNCT06414460
Recruiting
Phase 1
A Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Initial Efficacy of HRS-4508 Monotherapy in Patients With Advanced or Metastatic Solid Tumors
Advanced Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.290 enrolledNCT06598735
Recruiting
Phase 3
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Squamous Cell Carcinoma of Head and Neck
Janssen Research & Development, LLC500 enrolled198 locationsNCT07276399
Recruiting
Phase 2
Phase II Study of Sacituzumab Tirumotecan in Combination With Osimertinib for Neoadjuvant Treatment in Patients With Resectable Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
Non-small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.30 enrolled1 locationNCT07329322